-
1 Comment
ARYA Sciences Acquisition Corp III is currently in a long term downtrend where the price is trading 6.8% below its 200 day moving average.
From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Financial Services sector with a price to sales ratio of 0.0.
ARYA Sciences Acquisition Corp III's total revenue sank by nan% to $0 since the same quarter in the previous year.
Its net income has dropped by 100.1% to $-523 since the same quarter in the previous year.
Finally, its free cash flow grew by 100.1% to $109 since the same quarter in the previous year.
Based on the above factors, ARYA Sciences Acquisition Corp III gets an overall score of 2/5.
| Industry | Shell Companies |
|---|---|
| Exchange | NASDAQ |
| CurrencyCode | USD |
| ISIN | KYG3166W1069 |
| Sector | Financial Services |
| Market Cap | 214M |
|---|---|
| PE Ratio | None |
| Dividend Yield | 0.0% |
| Beta | nan |
| Target Price | 24.89 |
ARYA Sciences Acquisition Corp III does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities in the healthcare industry. The company was incorporated in 2020 and is based in New York, New York.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for ARYA using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
